We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 287.00
Bid: 285.50
Ask: 289.00
Change: 0.00 (0.00%)
Spread: 3.50 (1.226%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 287.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

Tue, 06th Apr 2021 07:53

(Alliance News) - Stock prices in London are seen opening higher on Tuesday after the long Easter holiday weekend, driven by robust US economic data.

In early company news, BP paved the way for share buybacks after the oil major hit its debt reduction target ahead of schedule. Accounting software provider Sage Group sold its Swiss business. Home emergency cover provider Homeserve expects annual profit in line with market forecasts.

IG futures indicate the FTSE 100 index is to open 32.70 points higher at 6,770.00. The blue-chip index closed up 23.67 points, or 0.4%, at 6,737.30 on Thursday.

BP said it expects to hit its USD35 billion net debt target during the first quarter of 2021, due to the early delivery of disposal proceeds and a positive operating performance.

BP had previously guided that it would get its debt down to USD35 billion by the end of 2021. It had said net debt actually was expected to increase during the first half, due to severance payments, a payment to Noway's Equinor for the completion of their US offshore wind joint venture, and BP's annual USD1.2 billion Gulf of Mexico oil spill redress payment.

The oil major said during the first quarter it has received around USD4.7 billion of disposal proceeds, the largest being USD2.4 billion for the sale of its 20% interest in Oman's Block 61.

BP now expects disposal proceeds in 2021 to be at the top end of the previously announced USD4 billion to USD6 billion range.

BP also reported a strong business performance during the first quarter, driven by "trading, the price environment and resilient operations".

On reaching this net debt target, BP said it is committed to returning at least 60% of surplus cash flow to shareholders by way of share buybacks, which it announce further details on at its first quarter results on April 27.

"We are pleased to announce that we now expect to have reached our USD35 billion net debt target during the first quarter 2021. This is a result of earlier than anticipated delivery of disposal proceeds combined with very strong business performance during the first quarter. We look forward to updating the market at our first quarter results, including further information on share buybacks," said Chief Executive Officer Bernard Looney.

Sage Group said it has entered into an agreement for the sale of its Swiss business to Infoniqa, a provider of HR software solutions majority-owned by Warburg Pincus, for CHF50 million. The deal is expected to complete within the next twelve months.

Homeserve said it delivered a good performance in financial 2021, with pretax profit in line with consensus forecasts.

Homeserve estimates adjusted pretax profit for the year that ended March 31 to be around GBP191 million, up 5.5% from GBP181 million in financial 2020. Consensus adjusted pretax profit, the mean average of 16 analyst estimates, stands at GBP190.2 million.

Homeserve said renewed focus on homes during the virus pandemic highlighted the value of HomeServe's core propositions across its Membership and Home Experts businesses, it noted.

Oxford Biomedica said it has signed a new three-year development and supply agreement with German pharmaceutical company Boehringer Ingelheim for the manufacture and supply of viral vectors. The deal builds on the partnership started between the two companies in 2018.

"We now have a portfolio of partnerships spread across development of [chimeric antigen receptor T cells], [T-cell receptors] and in vivo gene therapeutics, utilising lentiviral vectors. We are proud to partner with Boehringer Ingelheim, a business with proven excellence in complex manufacturing projects, as well as expertise in developing innovative medicines for patients with serious unmet medical needs," said CEO John Dawson.

The call for a higher open in London stem from a strong close in the US on Monday, with the Dow Jones Industrial Average up 1.1%, S&P 500 up 1.4% and Nasdaq Composite up 1.7%.

The S&P 500 and Dow set new records on Monday, while the Nasdaq also saw strong gains, after data on Friday showed far more US jobs than expected were created last month, reinforcing the view of a strong recovery.

The US economy regained 916,000 jobs in March, the biggest increase since August, with nearly a third of the increase in the hard-hit leisure and hospitality sector, the Labor Department reported.

In addition, the service sector in the US grew at its fastest pace in almost seven years in March, increasing price pressure, according to a IHS Markit survey on Monday.

The IHS Markit US services purchasing managers' index of business activity came in at 60.4 points in March, up from 59.8 in February and the flash estimate for March of 60.0. Last month's reading was the highest since July 2014.

The Japanese Nikkei 225 index ended down 1.1% on Tuesday. In China, the Shanghai Composite closed up 0.5%, while the Hang Seng index in Hong Kong is up 2.0%.

China's services sector posted stronger growth in March, according to survey results issued on Tuesday, with hiring also picking up and optimism surging to its highest level in over 10 years.

The Caixin headline seasonally adjusted business activity index posted 54.3 points in March, improved from 51.5 in February. It was further above the 50.0 no change mark, suggesting growth quickened in March.

The pound was quoted at USD1.3912 early Tuesday, up from USD1.3830 at the London equities close Thursday.

UK Prime Minister Boris Johnson said Monday that non-essential stores, hairdressers and pub beer gardens will reopen from April 12 in England, but people must not be complacent about the risks still posed by coronavirus.

Confirming the next step on the road map out of lockdown, Johnson told a Downing Street press conference he was looking forward to a pint of beer in a week's time. But he said the difficulties facing countries in Europe illustrated the risks still posed by the pandemic.

Johnson's comments came as the government published the latest findings from its reviews of Covid status certification - so-called "vaccine passports" - and international travel. The review suggested a certification scheme could have an "important role to play both domestically and internationally, as a temporary measure" - but Johnson faces opposition from members of Parliament on both sides of the Commons who are concerned about the civil liberties implications.

The global travel taskforce review warned "the state of the pandemic abroad, and the progress of vaccination programmes in other countries" meant it was impossible to say yet whether foreign holidays would be allowed from May 17, the date earmarked as the earliest possible for the resumption of international trips.

The euro was priced at USD1.1812, up from USD1.1765 late Thursday. Against the yen, the dollar was trading at JPY110.20, lower from JPY110.60.

Brent oil was quoted at USD62.80 a barrel on Tuesday morning, down from USD63.63 late Thursday in London. Gold was trading at USD1,735.55 an ounce, higher against USD1,728.70.

The economic events calendar on Tuesday has eurozone unemployment at 1000 BST.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Nov 2022 11:22

SMALL-CAP WINNERS & LOSERS: ME Group upgrades outlook on robust demand

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

Read more
11 Oct 2022 09:33

LONDON BROKER RATINGS: Numis cuts Kingfisher but raises Next

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Oct 2022 11:04

SMALL-CAP WINNERS & LOSERS: Superdry swings to profit; Halfords falls

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

Read more
7 Oct 2022 10:30

Oxford Biomedica extends Oaktree relationship with new loan facility

(Alliance News) - Oxford Biomedica PLC on Friday said that it has completed the partial repayment and amendment of its Oaktree Capital Management LP loan facility, as it looks to extend its relationship with the US banking company further.

Read more
16 Sep 2022 10:51

SMALL-CAP WINNERS & LOSERS: Capita buoyed by contract win and disposal

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

Read more
15 Sep 2022 10:27

Oxford Biomedica swings to loss as Covid vaccine winds down

(Sharecast News) - Oxford Biomedica reported a 21% decrease in its first-half total revenue on Thursday, to £64m.

Read more
15 Sep 2022 10:16

Oxford BioMedica swings to interim loss as costs climb, revenue falls

(Alliance News) - Oxford BioMedica PLC on Thursday reported a swing to interim loss and a decline in interim revenue.

Read more
14 Sep 2022 09:57

IN BRIEF: Oxford BioMedica subsidiary signs deal with new partner

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Says subsidiary Oxford Biomedica Solutions LLC has signed a deal with an unnamed new partner, for an undisclosed sum. Says the deal gives the US-based, private biotechnology firm access to Oxford BioMedica Solutions's process and manufacturing platform.

Read more
8 Sep 2022 16:00

UK earnings, trading statements calendar - next 7 days

Friday 9 September 
Computacenter PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Mid Wynd International Investment Trust PLCFull Year Results
Monday 12 September 
ABCAM PLCHalf Year Results
Arcontech Group PLCFull Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Kape Technologies PLCHalf Year Results
Made Tech Group PLCFull Year Results
MP Evans Group PLCHalf Year Results
SigmaRoc PLCHalf Year Results
Tirupati Graphite PLCFull Year Results
Tuesday 13 September 
accesso Technology Group PLCHalf Year Results
Churchill China PLCHalf Year Results
Corero Network Security PLCHalf Year Results
Engage XR Holdings PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Fevertree Drinks PLCHalf Year Results
Futura Medical PLCHalf Year Results
Gateley Holdings PLCFull Year Results
Harworth Group PLCHalf Year Results
HeiQ PLCHalf Year Results
JTC PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocado Group PLCTrading Statement
Oxford Nanopore Technologies PLCHalf Year Results
Petra Diamonds LtdFull Year Results
Property Franchise Group PLCHalf Year Results
RBG Holdings PLCHalf Year Results
Smart Metering Systems PLCHalf Year Results
Team17 Group PLCHalf Year Results
Trustpilot Group PLCHalf Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Wednesday 14 September 
Anpario PLCHalf Year Results
Advanced Medical Solutions Group PLCHalf Year Results
BioPharma Credit PLCHalf Year Results
Blackbird PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Diurnal Group PLCHalf Year Results
Dunelm Group PLCFull Year Results
Epwin Group PLCHalf Year Results
Glenveagh Properties PLCHalf Year Results
ITM Power PLCFull Year Results
Niox Group PLCHalf Year Results
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Redrow PLCFull Year Results
Ricardo PLCFull Year Results
STM Group PLCHalf Year Results
Artisanal Spirits Co PLCHalf Year Results
Tullow Oil PLCHalf Year Results
Thursday 15 September 
Big Technologies PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Checkit PLCHalf Year Results
DFS Furniture PLCFull Year Results
Foresight Solar Fund LtdHalf Year Results
Gresham House PLCHalf Year Results
Hilton Food Group PLCHalf Year Results
IG Group Holding PLCQ1 Results
IGas Energy PLCHalf Year Results
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
MJ Gleeson PLCFull Year Results
Oxford BioMedica PLCHalf Year Results
Portmeirion Group PLCHalf Year Results
Regional REIT LtdHalf Year Results
Renishaw PLCFull Year Results
RTW Venture Fund LtdHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Wickes Group PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
7 Sep 2022 09:12

Oxford BioMedica shares up as license deal signed with new US partner

(Alliance News) - Oxford BioMedica PLC on Wednesday said it signed a license and supply agreement with an unnamed new partner.

Read more
7 Sep 2022 07:42

Oxford Biomedica inks LSA with new US biotech partner

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has struck a new licence and supply agreement with an unnamed US partner.

Read more
1 Aug 2022 14:30

EXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO role

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

Read more
26 Jul 2022 11:12

SMALL-CAP WINNERS & LOSERS: Reach and Wickes sink on dark outlook

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

Read more
26 Jul 2022 11:09

Oxford BioMedica begins new project and signs license agreement

(Alliance News) - Oxford BioMedica PLC on Tuesday said it started a new project and signed a license and supply agreement.

Read more
26 Jul 2022 08:44

Oxford Biomedica inks LSA with US biotech firm, launches new project with Orchard Therapeutics

(Sharecast News) - Gene and cell therapy group Oxford Biomedica inked a new licence and supply agreement with an unnamed US private biotechnology on Tuesday company and also launched a new project with Orchard Therapeutics.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.